PFDeNA
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- 2018-10-29
- Valid until
- still holds
- Published
- 2018-10-28
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-09 · its source page states the value and the date
- Confidence
- 0.70
Sources
“Oct. 29, 2018, Tokyo Japan – Preferred Networks, Inc. and PFDeNA Inc. will start research and development to create a blood test system that utilizes deep learning technology to detect 14 types of cancers *1 in their early stages.”— what the page says, read 2026-11-09
Cite this claim
Plain text
AsOf. "Preferred Networks partnership: PFDeNA", as of 2018-10-29. Claim clm_2FAB829263B5, https://asof.is/claim/clm_2FAB829263B5, accessed 2026-11-09. Source: https://www.preferred.jp/en/news/pr20181029.
APA
AsOf. (2018). Preferred Networks partnership: PFDeNA (as of 2018-10-29) [Record clm_2FAB829263B5]. Retrieved November 9, 2026, from https://asof.is/claim/clm_2FAB829263B5 (source: https://www.preferred.jp/en/news/pr20181029)
BibTeX
@misc{asof_clm_2FAB829263B5,
author = {AsOf},
title = {Preferred Networks partnership: PFDeNA},
year = {2018},
howpublished = {\url{https://asof.is/claim/clm_2FAB829263B5}},
note = {Claim clm\_2FAB829263B5, as of 2018-10-29; source: https://www.preferred.jp/en/news/pr20181029},
urldate = {2026-11-09}
}On the record
/claim/clm_2FAB829263B5.md/v1/claims/clm_2FAB829263B5submit a correction